Stay updated on Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.

Latest updates to the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page
- Check6 days agoChange DetectedThe site footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check13 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.2%

- Check20 days agoChange DetectedThe website footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check27 days agoChange DetectedThe footer revision label was updated from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check47 days agoChange DetectedA new revision entry v3.7.0 was added to the history, replacing the previous v3.6.6. This indicates an update to the page's revision record.SummaryDifference0.0%

- Check68 days agoChange DetectedA new revision entry (151) dated 2026-08-28 adds Study Status, Contacts/Locations, Outcome Measures, and Study Design to the record history and updates the revision to v3.6.6. The history also removes the 2025-12-24 entry for Revision: v3.6.5.SummaryDifference0.3%

Stay in the know with updates to Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.